Elimination of Egfr-Overexpressing Cancer Cells by CD32 Chimeric Receptor T Cells in Combination with Cetuximab or Panitumumab
暂无分享，去创建一个
S. Ferrone | D. Lauro | A. Venditti | R. Arriga | D. Pastore | G. Sconocchia | B. Savoldo | G. Dotti | S. Caratelli | A. Ottaviani | Hongwei Du | M. D. del Principe | C. Cenciarelli | T. Sconocchia | G. Lanzilli | Elisa Landoni